Completed PHASE2 INTERVENTIONAL 1-arm NCT00604331

Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation

Sponsor: Herzzentrum Goettingen

Conditions Acute Myocardial Infarction Heart Failure Shock, Cardiogenic

Interventions Pyruvate

Updated 6 times since 2017 Last updated: Dec 7, 2010 Started: Aug 31, 2008 Primary completion: Jul 31, 2009 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00604331, this PHASE2 trial focuses on Acute Myocardial Infarction and Heart Failure and remains completed. Sponsored by Herzzentrum Goettingen, it has been updated 6 times since 2008, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Aug 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Herzzentrum Goettingen

Data source: Herzzentrum Goettingen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Göttingen, Germany